Healthcare Global Enterprises Limited — Updates, 16-02-2025: Press Release

Healthcare Global Enterprises Limited (HCG) reported robust financial results for the third quarter and nine months of FY25, with revenues reaching ₹558 crores, an increase of 19% year-on-year. Adjusted EBITDA rose by 15% to ₹923 million, while profit after tax climbed 23% to ₹371 million. Established centers grew by 20%, contributing significantly to the overall performance, while emerging centers surged by 25%. Notably, the Kolkata center saw a substantial 40% growth, indicating strong demand in underserved markets.

Operationally, HCG improved overall ARPOB to ₹44,284, and RoCE for established centers stood at 13.7%. The company is expanding its footprint by establishing new centers in Odisha, complementing its strategy for enhancing patient access. HCG's acquisition of MG Hospital in Vizag is expected to strengthen its regional presence.

Looking forward, the management emphasizes commitment to innovative, patient-centric cancer care, predicting continued growth driven by advancements in technology and personalized treatment models. Positive outlook as demand for cancer care escalates across India.